Participants
Contact
Several media, including the Diari de Girona, Diario Medico, EFE ciencia and international media such as Medical News and ScienceDaily, have echoed the article published by Antonio Zorzano’s lab on the role of DOR protein in muscle atrophy. The results of this study may provide a solution for the muscle deterioration associated with advanced age and with several diseases, such as AIDS or cancer.
See the press resume (PDF)
Related News
9 April 2014
Identified a new possible target to combat muscle wasting
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
